Anatomic Endoscopic Prostate Enucleation and BICEP Classification
Launched by NECMETTIN ERBAKAN UNIVERSITY · Jun 14, 2024
Trial Information
Current as of July 01, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Insufficient knowledge exists about bladder injuries during morcellation, as the existing literature primarily consists of isolated case reports. The Bladder Injury Classification System for Endoscopic Procedures (BICEP) aims to standardize the reporting and management of bladder injuries during endoscopic surgeries.
This study proposes an external validation of the BICEP system through an international, multicenter, prospective observational study. The objectives of this study are fourfold:
Validate the newly developed BICEP classification system with real-life clinical scenarios to ensu...
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Patients aged ≥40
- • ASA (American Society of Anesthesiologists) score ≤3
- • Estimated weight on ultrasound (USG) ≥40 grams for prostate weight
- • Patients undergoing Holmium Laser Enucleation of the Prostate (HoLEP) or Transurethral Resection of the Prostate (TURP) surgery.
- Exclusion Criteria:
- • Patients with neurological disorders that may affect bladder function, such as cerebrovascular stroke or Parkinson's disease.
- • Patients with active urinary tract infection.
- • Patients diagnosed with bladder cancer within the last 2 years.
- • Patients with prostate cancer.
- • Patients who have undergone previous prostate surgery.
About Necmettin Erbakan University
Necmettin Erbakan University is a prominent academic institution dedicated to advancing health sciences and research through innovative clinical trials. With a commitment to excellence in education and research, the university leverages its multidisciplinary approach to foster collaborations that enhance patient care and medical advancements. By conducting rigorous clinical studies, Necmettin Erbakan University seeks to contribute valuable insights to the medical community, ultimately improving treatment outcomes and fostering evidence-based practices in healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Konya, , Turkey
Patients applied
Trial Officials
Selçuk Güven, Prof. Dr.
Study Director
Necmettin Erbakan University
Bülent Erkurt, Prof. Dr.
Study Chair
Istanbul Medipol University Hospital
Selim Soytürk, RA
Principal Investigator
Necmettin Erbakan University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported